Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AAV8-mediated Low Density Lipoprotein Receptor (LDLR) Gene Replacement in Subjects With Homozygous Familial Hypercholesterolemia (HoFH)

NCT02651675 is registered in ClinicalTrials.gov with REGENXBIO Inc. as lead sponsor.

NCT NCT02651675
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02651675 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AAV8-mediated Low Density Lipoprotein Receptor (LDLR) Gene Replacement in Subjects With Homozygous Familial Hypercholesterolemia (HoFH)
Lead sponsor
REGENXBIO Inc.
Phase
Phase 1/2
Overall status
Terminated
Start date
March 31, 2016
Completion date
November 27, 2020
Enrollment
9 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

homozygous familial hypercholesterolemia (hofh)